Your browser doesn't support javascript.
loading
CAPG facilitates diffuse large B-cell lymphoma cell progression through PI3K/AKT signaling pathway.
Wang, Ganggang; Liu, Hu; An, Lin; Hou, Shuling; Zhang, Qiaohua.
Afiliación
  • Wang G; Department of Lymphatic Oncology, Cancer Center of Shanxi Bethune Hospital (The Third Hospital of Shanxi Medical University), Taiyuan City, Shanxi Province 030032, China. Electronic address: drwanggangg@163.com.
  • Liu H; Department of Lymphatic Oncology, Cancer Center of Shanxi Bethune Hospital (The Third Hospital of Shanxi Medical University), Taiyuan City, Shanxi Province 030032, China.
  • An L; Graduate School of Shanxi Medical University, Taiyuan City, Shanxi Province 030001, China.
  • Hou S; Department of Lymphatic Oncology, Cancer Center of Shanxi Bethune Hospital (The Third Hospital of Shanxi Medical University), Taiyuan City, Shanxi Province 030032, China.
  • Zhang Q; Department of Lymphatic Oncology, Cancer Center of Shanxi Bethune Hospital (The Third Hospital of Shanxi Medical University), Taiyuan City, Shanxi Province 030032, China.
Hum Immunol ; 83(12): 832-842, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36244872
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Fosfatidilinositol 3-Quinasas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Hum Immunol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Fosfatidilinositol 3-Quinasas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Hum Immunol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos